Galectin Therapeutics (GALT) Current Leases (2020 - 2026)
Galectin Therapeutics' quarterly Current Leases came in at $6000.0 in Q1 2026, down 91.18% year-on-year from $68000.0 in Q1 2025, and down 72.73% quarter-over-quarter from $22000.0 in Q4 2025.
Galectin Therapeutics has reported Current Leases for 7 years, with the latest figure at $6000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 91.18% year-over-year to $6000.0; the trailing twelve-month figure through Mar 2026 stood at $6000.0 (down 91.18% YoY), and the FY2025 full-year result was $22000.0, up 15.79% from the prior year.
- Current Leases for Q1 2026 stood at $6000.0, down from $22000.0 in the prior quarter.
- The five-year high for Current Leases was $68000.0 in Q1 2025, with the low at $6000.0 in Q1 2026.
- Average Current Leases over 5 years is $36764.7, with a median of $40000.0 recorded in 2022.
- Year-over-year, Current Leases surged 400.0% in 2022 and plunged 91.18% in 2026.
- Tracing GALT's Current Leases over 5 years: stood at $40000.0 in 2022, then rose by 15.0% to $46000.0 in 2023, then sank by 58.7% to $19000.0 in 2024, then climbed by 15.79% to $22000.0 in 2025, then slumped by 72.73% to $6000.0 in 2026.
- The last three Current Leases figures came in at $6000.0 (Q1 2026), $22000.0 (Q4 2025), and $37000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Mar 31, 2025 | 68,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 40,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Dec 31, 2020 | 44,000.00 |